Cargando…

P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING

Detalles Bibliográficos
Autores principales: Chary Nimmagadda, Subbaiah, Marie Budde, Paulina, Sun, Kaiyan, Covey, Todd, Krejsa, Cecile, Rothbaum, Wayne P., von Bubnoff, Nikolas, Khandanpour, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431568/
http://dx.doi.org/10.1097/01.HS9.0000970924.17451.f3
_version_ 1785091232023707648
author Chary Nimmagadda, Subbaiah
Marie Budde, Paulina
Sun, Kaiyan
Covey, Todd
Krejsa, Cecile
Rothbaum, Wayne P.
von Bubnoff, Nikolas
Khandanpour, Cyrus
author_facet Chary Nimmagadda, Subbaiah
Marie Budde, Paulina
Sun, Kaiyan
Covey, Todd
Krejsa, Cecile
Rothbaum, Wayne P.
von Bubnoff, Nikolas
Khandanpour, Cyrus
author_sort Chary Nimmagadda, Subbaiah
collection PubMed
description
format Online
Article
Text
id pubmed-10431568
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315682023-08-17 P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING Chary Nimmagadda, Subbaiah Marie Budde, Paulina Sun, Kaiyan Covey, Todd Krejsa, Cecile Rothbaum, Wayne P. von Bubnoff, Nikolas Khandanpour, Cyrus Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431568/ http://dx.doi.org/10.1097/01.HS9.0000970924.17451.f3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Chary Nimmagadda, Subbaiah
Marie Budde, Paulina
Sun, Kaiyan
Covey, Todd
Krejsa, Cecile
Rothbaum, Wayne P.
von Bubnoff, Nikolas
Khandanpour, Cyrus
P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title_full P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title_fullStr P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title_full_unstemmed P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title_short P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
title_sort p1005: effect of tl-895, a novel bruton’s tyrosine kinase inhibitor (btki), on oncogenic janus kinase 2-v617f (jak2vf) signaling
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431568/
http://dx.doi.org/10.1097/01.HS9.0000970924.17451.f3
work_keys_str_mv AT charynimmagaddasubbaiah p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT mariebuddepaulina p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT sunkaiyan p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT coveytodd p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT krejsacecile p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT rothbaumwaynep p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT vonbubnoffnikolas p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling
AT khandanpourcyrus p1005effectoftl895anovelbrutonstyrosinekinaseinhibitorbtkiononcogenicjanuskinase2v617fjak2vfsignaling